PPARA and Hepatic fibrosis: A study conducted by Pawlak et al. revealed that mice with a mutation in the DNA-binding domain (DBD) of PPARα, which limits its transcriptional activity to transrepression, are protected from liver inflammation and do not develop liver fibrosis in a dietary-induced metabolic-associated steatohepatitis (MASH) model [92].